<?xml version="1.0" encoding="UTF-8"?>
<p>Vast resources have been dedicated to shifting the diagnosis of bronchogenic cancer to its early stages. Poor survival can be largely attributed to delayed diagnosis. Only small resectable stage I tumors offer favorable prognosis with 5-year survival rates of 70% to 90%.
 <sup>[
  <xref rid="R3" ref-type="bibr">3</xref>]
 </sup>
</p>
